- Home
- SNTI vs MLSS Comparison
SNTI vs MLSS Comparison
Compare SNTI & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MLSS
- Stock Information
- Founded
- SNTI 2016
- MLSS 1989
- Country
- SNTI United States
- MLSS United States
- Employees
- SNTI N/A
- MLSS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- SNTI Health Care
- MLSS Health Care
- Exchange
- SNTI Nasdaq
- MLSS Nasdaq
- Market Cap
- SNTI 39.6M
- MLSS 42.4M
- IPO Year
- SNTI N/A
- MLSS 1995
- Fundamental
- Price
- SNTI $1.39
- MLSS $0.54
- Analyst Decision
- SNTI Strong Buy
- MLSS Buy
- Analyst Count
- SNTI 2
- MLSS 1
- Target Price
- SNTI $8.50
- MLSS $1.25
- AVG Volume (30 Days)
- SNTI 121.1K
- MLSS 61.1K
- Earning Date
- SNTI 11-13-2025
- MLSS 11-13-2025
- Dividend Yield
- SNTI N/A
- MLSS N/A
- EPS Growth
- SNTI N/A
- MLSS N/A
- EPS
- SNTI N/A
- MLSS N/A
- Revenue
- SNTI N/A
- MLSS $9,083,205.00
- Revenue This Year
- SNTI N/A
- MLSS $17.24
- Revenue Next Year
- SNTI $150.00
- MLSS $14.58
- P/E Ratio
- SNTI N/A
- MLSS N/A
- Revenue Growth
- SNTI N/A
- MLSS 7.84
- 52 Week Low
- SNTI $1.26
- MLSS $0.38
- 52 Week High
- SNTI $16.94
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- SNTI 39.50
- MLSS 37.62
- Support Level
- SNTI $1.33
- MLSS $0.55
- Resistance Level
- SNTI $1.42
- MLSS $0.65
- Average True Range (ATR)
- SNTI 0.07
- MLSS 0.04
- MACD
- SNTI 0.02
- MLSS -0.01
- Stochastic Oscillator
- SNTI 44.83
- MLSS 6.50
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.